A. Trocha

发表

Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection

E. Rosenberg, B. Walker, S. Kalams, 1999, Journal of Virology.

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

B. Walker, T. Harrer, S. Kalams, 1996, Journal of immunology.

Levels of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Effector and Memory Responses Decline after Suppression of Viremia with Highly Active Antiretroviral Therapy

B. Walker, S. Kalams, N. Jones, 1999, Journal of Virology.

Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid

Todd M. Allen, T. Allen, B. Walker, 2008, Journal of Virology.

Track A Basic Science

S. Sugden, D. Hazuda, F. Pereyra, 2012, Journal of the International AIDS Society.

Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class II1

B. Walker, C. Brander, A. Trocha, 2004, The Journal of Immunology.

Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms

R P Johnson, B. Walker, O. Yang, 1997, Journal of virology.

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

Terri Wrin, E. Rosenberg, F. Pereyra, 2008, The Journal of infectious diseases.

Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine

R. Siliciano, B. Walker, A. Trocha, 1994, Journal of virology.

HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition

Bin Li, Zabrina L. Brumme, Christian Brander, 2008, Journal of Virology.

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy

Richard H. Liang, Bradley R. Jones, B. Walker, 2021, bioRxiv.

Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone

B. Walker, A. Trocha, R. Johnson, 1993, Journal of virology.

Semen of HIV-Infected Individuals Detection of HIV-1-Specific CTLs in the Anderson

S. Kalams, A. Trocha, K. Mayer, 1998 .

Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals.

S. Kalams, A. Trocha, D. Anderson, 1998, Journal of immunology.

Elite control of HIV infection: implications for vaccines

E. Rosenberg, F. Pereyra, T. Miura, 2006, Retrovirology.

Immune modulation of human B lymphocytes by gene transfer with recombinant Epstein-Barr virus amplicons.

A. Trocha, R. Johnson, D. Seldin, 1998, Journal of virological methods.

Distinct Trafficking Pathways Mediate Nef-Induced and Clathrin-Dependent Major Histocompatibility Complex Class I Down-Regulation

B. Walker, A. Trocha, S. Le Gall, 2000, Journal of Virology.

Antigen on HLA Class I and Class II Cross-Presentation of Exogenous HIV Heat Shock Protein-Mediated

B. Walker, C. Brander, A. Trocha, 2004 .

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes

D. Irvine, B. Walker, A. Trocha, 2016, PLoS pathogens.

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD 4 T-Cells to Recognition by Cytotoxic T-Lymphocytes Citation

Darrell, B. Walker, A. Trocha, 2016 .

Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.

M. Altfeld, B. Walker, C. Brander, 2003, Journal of immunological methods.

HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response1

Philip J. R. Goulder, Todd M. Allen, Simon Mallal, 2005, The Journal of Immunology.

Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.

O. Yang, Ayub Ali, C. Brander, 2006, Blood.

Anti-APOBEC3G Activity of HIV-1 Vif Protein Is Attenuated in Elite Controllers

H. Jessen, F. Pereyra, T. Miura, 2015, Journal of Virology.

Reduced Replication Capacity of NL4-3 Recombinant Viruses Encoding Reverse Transcriptase–Integrase Sequences From HIV-1 Elite Controllers

Todd M. Allen, D. Heckerman, F. Pereyra, 2011, Journal of acquired immune deficiency syndromes.

Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers

E. Rosenberg, H. Jessen, F. Pereyra, 2010, Journal of Virology.

HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers

F. Pereyra, T. Miura, B. Walker, 2009, Journal of Virology.

HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1

Todd M. Allen, D. Heckerman, F. Pereyra, 2008, Journal of Virology.

Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.

R P Johnson, B. Walker, B. Korber, 1998, The Journal of clinical investigation.

Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization.

R. Siliciano, A. Trocha, J. Safrit, 1999, Journal of immunology.

Cytosolic Localization Dependence on TAP1/2 and Mechanisms for for Class I-Restricted Recognition: Processing of HIV-1 Envelope Glycoprotein

R. Siliciano, A. Trocha, J. Safrit, 1999 .

A viral CTL escape mutation leading to immunoglobulin-like transcript 4–mediated functional inhibition of myelomonocytic cells

Todd M. Allen, E. Rosenberg, F. Pereyra, 2007, The Journal of experimental medicine.

Selective Depletion of High-Avidity Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T Cells after Early HIV-1 Infection

Eric S. Rosenberg, Todd M. Allen, E. Rosenberg, 2007, Journal of Virology.

Evolution and transmission of stable CTL escape mutations in HIV infection

Michael Bunce, Robert Funkhouser, Christian Brander, 2001, Nature.

Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences

W. Blattner, B. Walker, Steven Wolinsky, 1999, Journal of Virology.

Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation

B. Walker, A. Trocha, R. Johnson, 1992, The Journal of experimental medicine.

Limited Sequence Evolution within Persistently Targeted CD8 Epitopes in Chronic Human Immunodeficiency Virus Type 1 Infection

Todd M. Allen, Spyros A. Kalams, B. Walker, 2005, Journal of Virology.

Impacts of Avidity and Specificity on the Antiviral Efficiency of HIV-1-Specific CTL 1

B. Walker, O. Yang, S. Kalams, 2003, The Journal of Immunology.

Antiviral Efficiency of HIV-1-Specific CTL Impacts of Avidity and Specificity on the

B. Walker, O. Yang, A. Trocha, 2003 .

Response Emergence of a Variant-Specific CTL HIV-1 Viral Escape in Infancy Followed by Altfeld ,

Todd M. Allen, M. Altfeld, B. Walker, 2005 .

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes

R P Johnson, B. Walker, O. Yang, 1996, Journal of virology.

HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition

Todd M. Allen, F. Pereyra, T. Miura, 2009, Journal of Virology.

Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes

Todd M. Allen, D. Heckerman, F. Pereyra, 2008, Journal of Virology.

Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children

E. Rosenberg, M. Altfeld, B. Walker, 2000, The Journal of experimental medicine.

Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot Assay

E. Rosenberg, M. Altfeld, B. Walker, 2000, Journal of Virology.

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire

B. Walker, S. Kalams, A. Trocha, 1994, The Journal of experimental medicine.

Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors.

E. Rosenberg, F. Pereyra, B. Walker, 2008, Blood.

Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes

D. Irvine, B. Walker, A. Trocha, 2014, PLoS pathogens.

T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant

W. Blattner, B. Walker, T. Harrer, 1996, The Journal of experimental medicine.

Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1.

W. Blattner, B. Walker, S. Kalams, 1997, The Journal of clinical investigation.

specific specific CTL antiviral activity is epitope - Nef interference with HIV-1

O. Yang, Ayub Ali, C. Brander, 2013 .

HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.

B. Walker, A. Trocha, R. Johnson, 1991, Journal of immunology.

Persistence of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Clones in a Subject with Rapid Disease Progression

S. Kalams, S. Buchbinder, A. Shea, 2001, Journal of Virology.

Migration ofAntigen-Specific T Cells Away from CXCR4-Binding Human ImmunodeficiencyVirus Type 1gp120

B. Walker, R. Wyatt, A. Trocha, 2004, Journal of Virology.

Curing HIV will require eliminating the reservoir of integrated, replication-competent proviruses

Richard H. Liang, B. Walker, A. Trocha, 2021 .

ligand 1 in progressors up-regulation in controllers and selective increase by blockade of PD T cells : constitutive + specific CD 8 − Telomerase activity of HIV-1

E. Rosenberg, F. Pereyra, B. Walker, 2008 .

Persistence of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Clones in a Subject with Rapid Disease Progression

S. Kalams, S. Buchbinder, A. Shea, 2001, Journal of Virology.

Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.

R. Siliciano, B. Walker, A. Trocha, 1994, AIDS research and human retroviruses.